Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXP001 vs Brufen in healthy volunteers
NCT02050958Phase 1Completed
- Sponsor
- Oxford Pharmascience
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of oxprofen in pain and inflammation (2 arms), sponsored by Oxford Pharmascience. Primary endpoint: Gastric irritation as measured by a Lanza score at 7 days. Started Feb 2014; status: completed.
02
Drugs
oxprofen
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT02050958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02050958.